Novo Nordisk-Torrent inaugurates enhanced facility in GujaratIllustrative image – not actual.
Pharmaceutical company Novo Nordisk, in partnership with Torrent Pharma, inaugurated its expanded insulin manufacturing plant in Gujarat on 11 December 2017.

The entire facility is dedicated to Novo Nordisk. So far, Torrent Pharma has made an investment of Rs 60 crore in the plant which has the existing capacity of around 26 million vials.

Presently, the Indrad facility in Gujarat is able to meet around 70-75 percent of Novo's domestic requirement of insulin for the Indian market. Post expansion, the plant’s capacity will be raised to 30-35 percent.

The company will also launch new products.

← All latest storiesBack to top →